Bayesian cell therapy process optimization
Authors:
- 19 February 2024
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 121 (5) , 1569-1582
Abstract
Optimizing complex bioprocesses poses a significant challenge in several fields, particularly in cell therapy manufacturing. The development of customized, closed, and automated processes is crucial for their industrial translation and for addressing large patient populations at a sustainable price. Limited understanding of the underlying biological mechanisms, coupled with highly resource‐intensive experimentation, are two contributing factors that make the development of these next‐generation processes challenging. Bayesian optimization (BO) is an iterative experimental design methodology that addresses these challenges, but has not been extensively tested in situations that require parallel experimentation with significant experimental variability. In this study, we present an evaluation of noisy, parallel BO for increasing noise levels and parallel batch sizes on two in silico bioprocesses, and compare it to the industry state‐of‐the‐art. As an in vitro showcase, we apply the method to the optimization of a monocyte purification unit operation. The in silico results show that BO significantly outperforms the state‐of‐the‐art, requiring approximately 50% fewer experiments on average. This study highlights the potential of noisy, parallel BO as valuable tool for cell therapy process development and optimization.Keywords
This publication has 43 references indexed in Scilit:
- Application of a Model Based on the Central Limit Theorem to Predict Growth of Pseudomonas spp. in Fish MeatFood and Bioprocess Technology, 2017
- The Translation of Cell-Based Therapies: Clinical Landscape and Manufacturing ChallengesRegenerative Medicine, 2015
- A comparison of two sampling methods for global sensitivity analysisComputer Physics Communications, 2012
- Optimization of a serum-free culture medium for mouse embryonic stem cells using design of experiments (DoE) methodologyCytotechnology, 2010
- Development of a serum-free medium for in vitro expansion of human cytotoxic T lymphocytes using a statistical designBMC Biotechnology, 2010
- Cell volume distributions reveal cell growth rates and division timesJournal of Theoretical Biology, 2009
- Quality by design for biopharmaceuticalsNature Biotechnology, 2009
- Bioprocess optimization using design‐of‐experiments methodologyBiotechnology Progress, 2008
- An unstructured kinetic model of macromolecular metabolism in batch and fed-batch cultures of hybridoma cells producing monoclonal antibodyBiochemical Engineering Journal, 2000
- Algorithm 659ACM Transactions on Mathematical Software, 1988